Discover the latest research, insights, and news on health equity and access today!
Scaling Value-Based Care: Addressing Systemic Issues With Innovative Payer-Provider Collaboration
A Highly Concentrated PBM Market Highlights Need for Policy Changes
Bacterial STIs in Men Living With HIV Associated With Drug Use in Sexual Context
Coverage Policies, Team Protocols Could Boost Spotty Uptake of Biomarker Testing in NSCLC
Biden-Harris Administration Expands Mental Health Coverage Protections Nationwide
Addressing Gender Disparities in Secondary Heart Disease Prevention
The Role of Social Determinants of Health in Respiratory Care Disparities
Lung Cancer Detection Worldwide: Meeting Patients Where They Are
Health Equity & Access Weekly Roundup: September 7, 2024
5 Underrecognized Social Determinants of Health
The Feasibility and Equity of Text Messaging to Determine Patient Eligibility for Lung Cancer Screening
Patients With Vitiligo Experience Poorer Quality of Life but Greater Health Care Access, Utilization
Comprehensive Care: The Key to Managing Diabetes and Its Complexities
Dr Javed Butler Explains How Finerenone Is Shaping New Treatment Standards for HF
Key Takeaways for Biosimilar Utilization
Promising Therapy Approaches for Advanced Friedreich Ataxia
ASCO 2024 and Beyond: Addressing NSCLC Unmet Needs and Future Research Directions
Strategies for Prevention and Screening of CRM Conditions
BOREAS Trial: New Findings on Type 2 Inflammation in COPD
Optum Care's Dr Ken Cohen Advocates for Comorbidity-Based GLP-1 Tiering for Patients With Diabetes
HMA Persistence and Effectiveness in Higher Risk MDS
Oral vs. Injectable HMAs: Convenience and Efficacy in Higher Risk MDS
EMPOWER-Lung 1 Trial Data Showcase Promise of Cemiplimab in NSCLC
A Patient's Perspective: The Value of Shared Decision-Making
Scaling Value-Based Care: Addressing Systemic Issues With Innovative Payer-Provider Collaboration
Coverage Policies, Team Protocols Could Boost Spotty Uptake of Biomarker Testing in NSCLC
Overcoming Failures: Lessons From IPF Clinical Trials in the Past Year
The Feasibility and Equity of Text Messaging to Determine Patient Eligibility for Lung Cancer Screening
Antihyperglycemic Treatment Patterns for Chronic Kidney Disease and Type 2 Diabetes
When Is a Network Adequate? Consumer Perspectives on Network Adequacy Definitions
Building a Virtual Model for Care After Cancer
Revised EOM Offers More Favorable Opportunities for Community Practices, Experts Say
Collaborative Innovation: Flatiron Health and Canopy Partner to Streamline Continuous Care for Oncology Practices
Geographic Variability of Medicaid Acceptance Among Allergists in the US
The Accelerated Approval Program for Oncology Drugs: Celebrating More Than 250,000 Life-Years Gained and Counting
A Machine Learning Technology for Addressing Medication-Related Risk in Older, Multimorbid Patients
Using NLP to Find “Hidden” Patients for Clinical Trials
Managed Care Approaches to Individualize Treatment of Hereditary Angioedema
AJMC® Powered by Patients and Managed Care Insights – More Than a Cosmetic Disease: Vitiligo Treatment Approaches and Raising Awareness of the Disease Burden
Maximizing Patient Outcomes in Ophthalmologic Diseases: How Managed Care Professionals Play a Key Role in Facilitating Uptake of Biosimilars
AMCP Nexus 2024
New and Emerging Treatment Strategies for Myasthenia Gravis: The Role of the Specialty Pharmacist
Managed Care Perspectives on the Burden of Food Allergies and Advances in Treatment
Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Caregiver Burden
PARP Inhibitors for Ovarian Cancer: An Oncology Pharmacist's Guide to the Latest Clinical Advancements
Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care
Managed Care Pharmacy: A Plan for the Future and How Pharmacists Are Leading the Way